By: James Pitt  Jul. 30, 2018
Osteoporosis is a common disease of aging, associated with weakened bones. Bone fractures are associated with higher subsequent mortality. According to University of Washington Medicine, “The one-year mortality following a hip fracture is 12 to 24%. It is estimated that 14% of deaths following a hip or pelvic fracture in previously ambulatory women were caused or hastened by the fracture.”
Read more47% of 90-Day Fracture Readmissions in Women Involve Osteoporosis, Which Tymlos May Help Address
By: James Pitt  May. 17, 2018
Osteoporosis is a disease that weakens bones and increases the risk of fracture, particularly common in elderly women. First-line treatment is with anti-resorptive drugs like bisphosphonates. A 2017 Lancet study found that patient concerns about bisphosphonates’ side effects limit their use. The American Society for Bone and Mineral Research (ASBMR) recommends that patients on bisphosphonates with low fracture risk take “drug holidays” to decrease their risk of serious side effects.
Read moreA Study of 30 Day Fracture Readmissions in Iowa Hospitals Highlights Importance of Tymlos
By: James Pitt  May. 02, 2018
Osteoporosis is a common disease among the Medicare population, which causes bones to lose density and makes them more susceptible to fracture. A 2004 Surgeon General's Report projected that half the women and one quarter of men in the US are likely to have at least one osteoporosis-related fracture in their lifetime.
Read more